Production (Stage)
Universal Ibogaine Inc.
IBO.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 78.24% | 15.64% | 54.20% | 12.76% | -286.09% |
| Total Depreciation and Amortization | -9.73% | 6.45% | -17.16% | 19.90% | -2.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.95% | -63.16% | -98.88% | 85.13% | 2,042.97% |
| Change in Net Operating Assets | -1,318.67% | -17.58% | 110.51% | -28.49% | -265.60% |
| Cash from Operations | 45.20% | 21.27% | -190.48% | 83.22% | -632.94% |
| Capital Expenditure | -- | -- | 94.41% | -0.70% | -108.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 94.41% | -0.70% | -108.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.56% | 0.00% | 73.77% | -273.09% | -1.24% |
| Issuance of Common Stock | -- | -- | -- | -77.84% | 212.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.84% | -- | -- | 72.25% | -10,337.50% |
| Cash from Financing | -109.37% | 1,254.27% | -715.79% | -99.18% | 121.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.27% | 162.75% | -181.79% | -193.19% | -48.65% |